Microbiome Research Services
11 services found
Manufactured by:Intus Biosciences, LLC based inFarmington, CONNECTICUT (USA)
Our cutting-edge Titan-1 platform powers complete ‘sample to answer’ services for pharma, biotech and research partners and clients, delivering response prediction, biomarker identification, and unprecedented insights into the role of the bacterial microbiome for any study or trial. The powerful platform can also support commercial laboratories ...
by:CosmosID based inGermantown, MARYLAND (USA)
Amplicon Sequencing has been an integral methodology for microbiologists and microbiome researchers for decades; enabling the generation of whole community analysis of bacteria or fungi in any complex sample. Like many metagenomic approaches, amplicon sequencing offers unique advantages to microbiome researchers, many of which ...
Manufactured by:DNA Genotek Inc., a subsidiary of OraSure Technologies, Inc. based inOttawa, ONTARIO (CANADA)
DNA Genotek understands the importance of streamlined operational workflows and enhancing awareness when conducting large-scale sample collections for human genomic and microbiome research or when offering a commercial service. The flexibility and expertise of our product customization and order fulfillment services enable you to focus on your genomic project ...
Manufactured by:Arc Bio, LLC. based inCambridge, MASSACHUSETTS (USA)
At Arc Bio, we believe that metagenomics has exciting applications in both established (e.g., infectious disease) and emerging (e.g., onco-microbiome) research areas. That is why we offer a full suite of bespoke wet lab and dry lab services that enables our partners to augment their existing capabilities and/or deploy their own metagenomics workflows in-house. ...
Manufactured by:Bio-Me based inOslo, NORWAY
Ship your samples to our PMP™ service laboratory – The fastest way to reliable results in your clinical microbiome research, without the need for in-house bioinformatics capabilities. Wide Range Of Proprietary Microbiome Analysis Solutions. Bio-Me offers a wide range of proprietary solutions to facilitate academia and pharma ...
by:CosmosID based inGermantown, MARYLAND (USA)
At CosmosID, we leverage our expertise in database curation to build a quality-controlled OTU database for both 16S and ITS amplicon sequencing using a range of open-source databases. Combined with the CosmosID Metagenomics Cloud, microbiome scientists can now can amplicon analysis in a matter of minutes, complete with charts and visualizations which are ready to export! ...
by:BioVenic based inSan Jose, CALIFORNIA (USA)
The collection of microbiota information makes it possible to analyze the interactions between complex traits and microbial communities in various parts of the animal and human body. The role of microorganisms in infectious diseases is widely known and symbiotic microorganisms also play an important role in laying the foundation for non-communicable diseases. MWAS (Microbiome-wide Association ...
by:CosmosID based inGermantown, MARYLAND (USA)
Through extensive R&D, the CosmosID team have established optimum read depth ranges for different samples types, using species and strain-level Bioinformatics. Whilst the optimum depth for any given sample will depend on study intent, microbial diversity & expected host DNA contamination, CosmosID offers shallow shotgun sequencing at 3M reads which yields consistent ...
by:PharmaBiome AG based inSchlieren, SWITZERLAND
We take a bottom-up approach and engineer bacterial consortia based on their interactions. Our deep understanding of function drives the selection of individual strains, which are then co-cultured using our proprietary ...
by:Biomcare ApS based inAarhus, DENMARK
It is often valuable to study the effect of a product on the gut microbiome or the influence of the microbiome on the effect of a new product, in a controlled setting that eliminates many of the confounding factors that affect the microbiome. Therefore, we offer in vivo tests of new products such as drugs and food ingredients including pre-tox studies, in an integrated workflow with microbiome ...
by:PharmaBiome AG based inSchlieren, SWITZERLAND
Leading-edge therapies that leverage the microbiome promise to address a range of serious diseases that currently don’t have adequate solutions. Microbiome-based therapies are de-risked thanks to the established proof-of-concept with fecal matter transplant ...